Classifying MMR variants: Time for revised nomenclature in Lynch syndrome

11Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Inactivating germline mutations in DNA mismatch repair (MMR) genes are diagnostic for Lynch syndrome. However, the clinical significance of missense variants is uncertain. A threshold level of compromised MLH1 expression, correlating with greater protein instability and MMR functional defect, has been identified to help classify the pathogenicity of missense variants. ©2013 AACR.

Cite

CITATION STYLE

APA

You, Y. N., & Vilar, E. (2013). Classifying MMR variants: Time for revised nomenclature in Lynch syndrome. Clinical Cancer Research, 19(9), 2280–2282. https://doi.org/10.1158/1078-0432.CCR-13-0392

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free